“Review of new biological drugs and JAK inhibitors approved for children and adolescents with moderate to severe atopic dermatitis: the situation in Uruguay”, Arch Pediatr Urug, vol. 97, no. 1, p. e801, Apr. 2026, doi: 10.31134/AP.97.1.20.